-
Product Insights
Deep Vein Thrombosis (DVT) Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2019" provides an overview of Deep Vein Thrombosis (DVT) clinical trials scenario. This report provides top line data relating to the clinical trials on Deep Vein Thrombosis (DVT). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Atrial Flutter - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Atrial Flutter - Global Clinical Trials Review, H2, 2021" provides an overview of Atrial Flutter Clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Chronic Heart Failure - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Chronic Heart Failure - Global Clinical Trials Review, H2, 2021" provides an overview of Chronic Heart Failure Clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type....
-
Product Insights
Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021" provides an overview of Tachycardia (Tachyarrhythmias) Clinical trials scenario. This report provides top line data relating to the clinical trials on Tachycardia (Tachyarrhythmias). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Pre-Eclampsia - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Pre-Eclampsia - Global Clinical Trials Review, H2, 2021" provides an overview of Pre-Eclampsia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
-
Product Insights
Chronic Thromboembolic Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Chronic Thromboembolic Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chronic Thromboembolic Pulmonary Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Thromboembolic Pulmonary Hypertension, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Aortic Valve Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Aortic Valve Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Aortic Valve Stenosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aortic Valve Stenosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Subarachnoid Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Subarachnoid Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Subarachnoid Hemorrhage pipeline landscape. The report provides comprehensive information on the therapeutics under development for Subarachnoid Hemorrhage, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Resistant Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Resistant Hypertension, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Atherosclerosis (or arteriosclerotic vascular disease) may occur with symptoms including chest pain (angina), pain in the leg, arm, and anywhere else that an artery is blocked, shortness of breath, fatigue, confusion (if the blockage affects circulation to the brain) and muscle weakness in the legs from lack of circulation. The Atherosclerosis pipeline drugs market research report outlays comprehensive information on the Atherosclerosis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA)...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.